Alfonso Tafur

Apixaban and dalteparin in active malignancy‐associated venous thromboembolism: The ADAM VTE trial

Robert D. McBane, Waldemar E. Wysokiński, Jennifer Le‐Rademacher et al. · Journal of Thrombosis and Haemostasis · 2019 · 554 citations

Thrombosis, Venous Thrombosis, Adam Vte Trial +6

Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19

Alex C. Spyropoulos, Mark Goldin, Dimitrios Giannis et al. · JAMA Internal Medicine · 2021 · 478 citations · Full text

Perioperative Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant

James D. Douketis, Alex C. Spyropoulos, Joanne Duncan et al. · JAMA Internal Medicine · 2019 · 474 citations · Full text

Perioperative Management of Antithrombotic Therapy

James D. Douketis, Alex C. Spyropoulos, M. Hassan Murad et al. · CHEST Journal · 2022 · 351 citations

Thrombosis, Venous Thrombosis, Medicine +9

Rivaroxaban versus no anticoagulation for post-discharge thromboprophylaxis after hospitalisation for COVID-19 (MICHELLE): an open-label, multicentre, randomised, controlled trial

Eduardo Ramacciotti, Leandro Barile Agati, Daniela Calderaro et al. · The Lancet · 2021 · 245 citations · Full text

Thrombosis, Hematology, Patient Safety +8